Notifications
Clear all
Mar 27, 2025 8:39 pm
- Saxenda (liraglutide) and Ozempic (semaglutide) are both GLP-1 receptor agonists, but they have different FDA-approved uses.
- Saxenda is FDA-approved for long-term weight management in individuals aged 12 years and older.
- Ozempic is FDA-approved for type 2 diabetes and reducing the risk of cardiovascular events and worsening kidney disease, though it may be prescribed off-label for weight loss.
- Dosing differs: Saxenda is injected once daily, while Ozempic is injected once weekly.
- Common side effects include nausea, diarrhea, and constipation.
- Studies suggest that Ozempic may lead to greater weight loss than Saxenda.
https://www.drugs.com/medical-answers/saxenda-ozempic-weight-loss-3577527/